Related Experiment Videos
New salicylate therapies for ulcerative colitis
1Department of Medicine, St Vincent's Medical Center of Richmond, Staten Island, New York.
Postgraduate Medicine
|September 1, 1990
Summary
Topical 5-aminosalicylic acid enemas offer advantages for ulcerative colitis treatment. New oral salicylate preparations may also provide benefits for patients with this chronic inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Sulfasalazine development significantly improved ulcerative colitis prognosis over 50 years ago.
- The active moiety of oral sulfasalazine, 5-aminosalicylic acid (5-ASA), is now available as a topical enema preparation.
Purpose of the Study:
- To review the advantages of 5-ASA enemas in treating ulcerative colitis.
- To examine potential benefits of new oral salicylate preparations.
Main Methods:
- Literature review of topical 5-ASA enemas.
- Review of new oral salicylate preparations.
Main Results:
- Topical 5-ASA enemas present distinct advantages for ulcerative colitis management.
- New oral salicylate formulations show potential therapeutic benefits.
Conclusions:
- Topical 5-ASA enemas represent a significant advancement in ulcerative colitis treatment.
- Further investigation into oral salicylate preparations is warranted.